发明名称 Solid state forms of vemurafenib hydrochloride
摘要 Provided herein are solid state forms of Vemurafenib hydrochloride, processes for preparing the solid state forms, as well as pharmaceutical compositions and formulations comprising said solid state forms.
申请公布号 US9440971(B2) 申请公布日期 2016.09.13
申请号 US201414772566 申请日期 2014.03.11
申请人 ratiopharm GmbH 发明人 Albrecht Wolfgang;Guserle Richard;Lehmann Frank
分类号 C07D401/02;C07D401/10;A61K31/4353;A61K31/437;C07D471/04 主分类号 C07D401/02
代理机构 Baker & Hostetler LLP 代理人 Baker & Hostetler LLP
主权项 1. A crystalline form of Vemurafenib hydrochloride salt, designated as Form II, characterized by one or more of the following: a powder X-ray diffraction pattern having peaks at 5.0, 9.9, 15.7, 19.8 and 22.1 degrees two theta±0.2 degrees two theta; a powder X-ray diffraction pattern substantially as depicted in FIG. 1; a solid-state 13C NMR spectrum having characteristic peaks at 51.0, 114.5, 132.3, 138.0 and 139.5 ppm, ±0.2 ppm; a solid state 13C NMR spectrum having chemical shift differences between said characteristic peaks and a peak at 120.9 ppm±0.2 ppm of −69.9, −6.4, 11.4, 17.1 and 18.6±0.1 ppm, respectively; a solid state 13C NMR spectrum substantially as shown in FIG. 3; or any combination of these data.
地址 Ulm DE